alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains information extracted from the consolidated balance
sheet and the consolidated statement of operations filed as part of the
annual report on Form 10-K and is qualified in its entirety by reference
to such quarterly report on Form 10-K.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                      13,658,827
<SECURITIES>                                         0
<RECEIVABLES>                                4,408,605
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            19,966,892
<PP&E>                                      53,936,003
<DEPRECIATION>                               (829,966)
<TOTAL-ASSETS>                              77,818,418
<CURRENT-LIABILITIES>                       12,850,400
<BONDS>                                     39,589,497
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    28,216,042
<OTHER-SE>                                 (3,706,094)
<TOTAL-LIABILITY-AND-EQUITY>                77,818,418
<SALES>                                              0
<TOTAL-REVENUES>                            16,038,242
<CGS>                                                0
<TOTAL-COSTS>                               17,687,616
<OTHER-EXPENSES>                             (513,532)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,135,842)
<INCOME-TAX>                                   409,363
<INCOME-CONTINUING>                          (726,479)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (726,479)
<EPS-PRIMARY>                                   (0.14)
<EPS-DILUTED>                                   (0.14)


</TABLE>
III 

112TH CONGRESS 

1ST SESSION S. RES. 134 

Supporting the designation of April as Parkinson’s Awareness Month. 

IN THE SENATE OF THE UNITED STATES 

APRIL 6 (legislative day, APRIL 5), 2011 

Ms. STABENOW (for herself, Mr. ISAKSON, Mr. UDALL of Colorado, Mr. 

JOHANNS, and Mrs. HUTCHISON) submitted the following resolution; 

which was considered and agreed to 

RESOLUTION 

Supporting the designation of April as Parkinson’s 

Awareness Month. 

Whereas Parkinson’s disease is the second most common 

neurodegenerative disease in the United States, second 

only to Alzheimer’s disease; 

Whereas even though there is inadequate comprehensive data 

on the incidence and prevalence of Parkinson’s disease, 

as of 2011, it is estimated that the disease affects over 

1,000,000 people in the United States; 

Whereas although research suggests the cause of Parkinson’s 

disease is a combination of genetic and environmental 

factors, the exact cause and progression of the disease is 

still unknown; 


sroberts on DSK69SOYB1PROD with BILLS
2 

•SRES 134 ATS 

Whereas there is no objective test for Parkinson’s disease, 

and the rate of misdiagnosis can be high; 

Whereas symptoms of Parkinson’s disease vary from person 

to person and include tremors, slowness, difficulty with 

balance, swallowing, chewing, and speaking, rigidity, cognitive problems, dementia, mood disorders, such as depression and anxiety, constipation, skin problems, and 

sleep disruptions; 

Whereas medications mask some symptoms of Parkinson’s 

disease for a limited amount of time each day, often with 

dose-limiting side effects; 

Whereas ultimately the medications and treatments lose their 

effectiveness, generally after 4 to 8 years, leaving the person unable to move, speak, or swallow; 

Whereas there is no cure, therapy, or drug to slow or halt 

the progression of Parkinson’s disease; and 

Whereas increased education and research are needed to help 

find more effective treatments with fewer side effects 

and, ultimately, an effective treatment or cure for Parkinson’s disease: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) supports the designation of April as Parkin3 son’s Awareness Month; 

4 (2) supports the goals and ideals of Parkinson’s 

5 Awareness Month; 

6 (3) continues to support research to find better 

7 treatments, and eventually, a cure for Parkinson’s 

8 disease; 


sroberts on DSK69SOYB1PROD with BILLS
3 

•SRES 134 ATS 

1 (4) recognizes the people living with Parkin2 son’s who participate in vital clinical trials to ad3 vance knowledge of this disease; and 

4 (5) commends the dedication of local and re5 gional organizations, volunteers, and millions of 

6 Americans across the country working to improve 

7 the quality of life of persons living with Parkinson’s 

8 disease and their families. 

Æ 


sroberts on DSK69SOYB1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S FORM 10-K FOR THE YEAR ENDED DECEMBER 31, 1998.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                       7,417,048
<SECURITIES>                                         0
<RECEIVABLES>                                2,384,309
<ALLOWANCES>                                 (354,000)
<INVENTORY>                                  1,168,054
<CURRENT-ASSETS>                            16,128,645
<PP&E>                                      15,590,909
<DEPRECIATION>                             (7,459,456)
<TOTAL-ASSETS>                              33,646,583
<CURRENT-LIABILITIES>                       24,044,527
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        302
<COMMON>                                        85,372
<OTHER-SE>                                   5,698,198
<TOTAL-LIABILITY-AND-EQUITY>                33,646,583
<SALES>                                    104,268,542
<TOTAL-REVENUES>                           104,268,542
<CGS>                                      102,814,267
<TOTAL-COSTS>                              102,814,267
<OTHER-EXPENSES>                             2,416,586
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             516,626
<INCOME-PRETAX>                            (1,478,937)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,478,937)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,478,937)
<EPS-PRIMARY>                                   (0.02)
<EPS-DILUTED>                                   (0.02)
        

</TABLE>
TEXAS COURT OF APPEALS, THIRD DISTRICT, AT AUSTIN

JUDGMENT RENDERED JUNE 12, 2019

NO. 03-18-00694-CV

Linda S. Nowlin, Appellant

v.

Samarra Davis, Appellee

APPEAL FROM COUNTY COURT AT LAW NO. 1 OF TRAVIS COUNTY

BEFORE JUSTICES KELLY, SMITH, AND SHANNON

AFFIRMED -- OPINION BY JUSTICE SHANNON

This is an appeal from the judgment signed by the trial court on July 25, 2018. Having reviewed 

the record and the parties’ arguments, the Court holds that there was no reversible error in the 

judgment. Therefore, the Court affirms the trial court’s judgment. Appellant shall pay all costs 

relating to this appeal, both in this Court and in the court below.
#### UNITED STATES of America, Plaintiff-Appellee, v. Ruby Jane GAYLOR, Defendant-Appellant.

No. 09-56967.

United States Court of Appeals, Ninth Circuit.

Submitted June 15, 2011.*

Filed July 1, 2011.

Daniel W. Layton, Esquire, Office of the U.S. Attorney, Los Angeles, CA, Michael J. Haungs, Christine Durney Mason, U.S. Department of Justice, Washington, DC, for Plaintiff-Appellee.

Ruby Jane Gaylor, Simi Valley, CA, pro se.

Before: CANBY, O’SCANNLAIN, and FISHER, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Ruby Jane Gaylor appeals pro se from the district court’s order permanently enjoining her from filing false tax documents or providing false tax documents to any persons or entities. We have jurisdiction under 28 U.S.C. § 1291. We review for an abuse of discretion the issuance of a permanent injunction. *United States v. Kapp,*564 F.3d 1103, 1109 (9th Cir.2009). We affirm.

The district court did not abuse its discretion by entering a permanent injunction preventing Gaylor from filing false tax documents or providing false tax documents to other persons or entities. *See*26 U.S.C. § 7402(a) (“The district courts of the United States at the instance of the United States shall have such jurisdiction to make and issue ... orders of injunction ... as may be necessary or appropriate for the enforcement of the internal revenue laws.”); *California ex rel. Lockyer v. U.S. Dep’t of Agrie.,*575 F.3d 999, 1019 (9th Cir.2009) (listing traditional permanent injunction factors).

Contrary to Gaylor’s contentions, the government’s service of process was not *479defective under Fed.R.Civ.P. 4(c)(2), nor was the government required to enter into a settlement agreement with her.

Gaylor’s remaining contentions are unpersuasive.

AFFIRMED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
<PAGE>

                                  BLUEFLY, INC.
                                 MARCH 31, 2003

                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of Bluefly, Inc. (the
"Company") on Form 10-Q for the period ending September 30, 2002, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Patrick C. Barry, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

         1. The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         2. The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

/s/ Patrick C. Barry

Patrick C. Barry
Chief Financial Officer
April 29, 2003

                                       22
<PAGE>


                                                                    EXHIBIT 32.1

                        CERTIFICATION OF PERIODIC REPORT



         Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C.
Section 1350, the undersigned officer of Renaissance Learning, Inc. (the
"Company"), hereby certifies that, to the undersigned's knowledge:

         (1)   the Company's Quarterly Report on Form 10-Q for the quarter ended
               September 30, 2003 (the "Report") fully complies with the
               requirements of Section 13(a) or 15(d), as applicable, of the
               Securities Exchange Act of 1934; and

         (2)   the information contained in the Report fairly presents, in all
               material respects, the financial condition and results of
               operations of the Company.


Dated: November 6, 2003


                                    /s/ John R. Hickey
                                    --------------------------------------------
                                    Name: John R. Hickey
                                    Title: President and Chief Executive Officer


THIS WRITTEN STATEMENT ACCOMPANIES THIS REPORT PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002 AND SHALL NOT BE DEEMED TO BE FILED BY THE COMPANY
FOR PURPOSES OF THE SECURITIES EXCHANGE ACT OF 1934.
# C_2020161EN.01001701.xml

| 11.5.2020 | EN | Official Journal of the European Union | C 161/17 |
| --- | --- | --- | --- |

11.5.2020

EN

Official Journal of the European Union

C 161/17

---

Appeal brought on 10 December 2019 by Esim Chemicals GmbH against the order of the General Court (Fourth Chamber) delivered on 9 October 2019 in Case T-713/18, Esim Chemicals v EUIPO

(Case C-902/19 P)

(2020/C 161/25)

Language of the case: English

Parties

Appellant: Esim Chemicals GmbH (represented by: I. Rungg, Rechtsanwalt, I. Innerhofer, Rechtsanwältin)

Other party to the proceedings: European Union Intellectual Property Office

By order of 3 March 2020 the Court of JusticeJustice (Chamber determining whether appeals may proceed) held that the appeal is not allowed to proceed and that Esim Chemicals GmbH shall bear its own costs.

---
# C_2021062EN.01003101.xml

| 22.2.2021 | EN | Official Journal of the European Union | C 62/31 |
| --- | --- | --- | --- |

22.2.2021

EN

Official Journal of the European Union

C 62/31

---

Order of the General Court of 18 December 2020 — Micreos Food Safety v Commission

(Case T-568/19) (1)

(Action for annulment - Public health - Regulation (EC) No 853/2004 - Phage-based product used to reduce the presence of the bacterial pathogen Listeria monocytogenes in animal-derived ready-to-eat food - Rejection of the request to approve ListexTM P100 as a decontaminant in animal-derived ready-to-eat food - Act not open to challenge - Act not intended to produce binding legal effects - Purely confirmatory act - Informative act - Inadmissibility)

(2021/C 62/38)

Language of the case: English

Parties

Applicant: Micreos Food Safety BV (Wageningen, Netherlands) (represented by: S. Pappas, lawyer)

Defendant: European Commission (represented by: B. Eggers, W. Farrell and I. Galindo Martín, acting as Agents)

Re:

Action pursuant to Article 263 TFEU seeking the annulment of the alleged decisions of the Commission of 17 June 2019 by which the Commission: (i) rejected the original application by the applicant for the approval of ListexTM P100 as a decontaminant in animal-derived ready-to-eat food, or re-examined that application; (ii) rejected the alternative application to regard ListexTM P100 as a non-decontaminating processing aid; and, (iii) prohibited the placing on the market of the European Union of that product as a processing aid in such food.

Operative part of the order

| 1. | The action is dismissed as inadmissible. |
| --- | --- |

1.

The action is dismissed as inadmissible.

| 2. | Micreos Food Safety BV shall pay the costs, including those of the interim proceedings. |
| --- | --- |

2.

Micreos Food Safety BV shall pay the costs, including those of the interim proceedings.

---

(1)  OJ C 372, 4.11.2019.

---
# C_2019182EN.01003801.xml

| 27.5.2019 | EN | Official Journal of the European Union | C 182/38 |
| --- | --- | --- | --- |

27.5.2019

EN

Official Journal of the European Union

C 182/38

---

Action brought on 5 April 2019 — Armani v EUIPO — Invicta Watch Company of America (GLYCINE)

(Case T-209/19)

(2019/C 182/43)

Language of the case: English

Parties

Applicant: Giorgio Armani SpA (Milan, Italy) (represented by: J. Rether and M. Kinkeldey, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Invicta Watch Company of America, Inc. (Hollywood, Florida, United States)

Details of the proceedings before EUIPO

Applicant of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: Application for European Union figurative mark in colours black and white — Application for registration No 15 910 301

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the Fourth Board of Appeal of EUIPO of 4 February 2019 in Case R 578/2018-4

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision; |
| --- | --- |

—

annul the contested decision;

| — | order the defendant to pay the costs of the proceedings. |
| --- | --- |

—

order the defendant to pay the costs of the proceedings.

Plea in law

| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |
| --- | --- |

—

Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.

---
# C_2019383EN.01003602.xml

| 11.11.2019 | EN | Official Journal of the European Union | C 383/36 |
| --- | --- | --- | --- |

11.11.2019

EN

Official Journal of the European Union

C 383/36

---

Request for a preliminary ruling from the Tribunalul Arbitral de pe lângă Asociația de arbitraj de pe lângă Baroul Cluj (Romania) lodged on 25 February 2019 — KE v LF

(Case C-185/19)

(2019/C 383/41)

Language of the case: Romanian

Referring court

Tribunalul Arbitral de pe lângă Asociația de arbitraj de pe lângă Baroul Cluj

Parties to the main proceedings

Applicant: KE

Defendant: LF

By Order of 24 September 2019, the Court (Sixth Chamber) declared the request for a preliminary ruling manifestly inadmissible and declared that it manifestly lacks jurisdiction to give a ruling thereon.

---
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA

F OURTH D ISTRICT

MICHAEL BRUENS, PATRICE BRUENS, ARDUINO MARINELLI, MARIANNE MARINELLI, KARIM AL I MI,

SOULA KASSIDI FAMILY TRUST and

227 BEACH BOULEVARD LIMITED PARTNERSHIP
, Appellant s ,

v.

Q CLUB HOTEL, LLC
, Appellee

.

No. 4D 17

- 1053

[ March 22, 2018 ]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, Broward County ; David A. Haimes , Judge; L.T. Case No. 12

- 029981 (08)

.

Alexander D. Varkas, III and Robert Sweetapple of Sweetapple, Broeke r & Varkas, PL, Boca Raton, for appellant s

.

E. Travis Ramey of B u rr & Forman LLP, Birmingham, AL, and Laurence S. Litow and Francesco A. Zincone of Burr & Forman LLP, Fort Lauderdale, for appellee.

P ER C URIAM

.

Affirmed.

G ERBER
, C.J., M AY and D AMOORGIAN
, JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
<TABLE> <S> <C>

<ARTICLE> 9
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          26,785
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     68,223
<INVESTMENTS-CARRYING>                          27,031
<INVESTMENTS-MARKET>                            26,869
<LOANS>                                        760,132
<ALLOWANCE>                                     11,034
<TOTAL-ASSETS>                                 901,555
<DEPOSITS>                                     736,398
<SHORT-TERM>                                    55,500
<LIABILITIES-OTHER>                              7,021
<LONG-TERM>                                      6,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        53,635
<OTHER-SE>                                      43,001
<TOTAL-LIABILITIES-AND-EQUITY>                 901,555
<INTEREST-LOAN>                                 55,874
<INTEREST-INVEST>                                5,863
<INTEREST-OTHER>                                     0
<INTEREST-TOTAL>                                61,737
<INTEREST-DEPOSIT>                              29,302
<INTEREST-EXPENSE>                              31,452
<INTEREST-INCOME-NET>                           30,285
<LOAN-LOSSES>                                    1,900
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                 13,886
<INCOME-PRETAX>                                 15,419
<INCOME-PRE-EXTRAORDINARY>                       9,108
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     9,108
<EPS-PRIMARY>                                     1.17
<EPS-DILUTED>                                     1.15
<YIELD-ACTUAL>                                   10.04
<LOANS-NON>                                      7,276
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                 1,389
<LOANS-PROBLEM>                                 10,346
<ALLOWANCE-OPEN>                                10,885
<CHARGE-OFFS>                                    1,855
<RECOVERIES>                                       104
<ALLOWANCE-CLOSE>                               11,034
<ALLOWANCE-DOMESTIC>                            11,034
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>